News & Updates

Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.

Individuals with poly(A)-specific ribonuclease (PARN) mutation are likely to have idiopathic pulmonary fibrosis (IPF), but other interstitial lung disease (ILD) subtypes may also occur, according to a study.

The progression of COVID-19 disease during pregnancy from asymptomatic or mild symptoms to moderate, severe, or critical symptoms is consistent regardless of trimester, according to a prospective study presented at SMFM 2022.

The risk of death is increased among patients with sarcoidosis compared with the general population, suggests a recent study, noting that mortality is even higher in those treated with systemic corticosteroids.

First data from Vaccine Allergy Safety (VAS) clinics in Hong Kong show that a majority of high-risk patients can receive coronavirus disease 2019 (COVID-19) vaccination safely, with no immediate allergic reactions.

The early addition of ivermectin to standard of care (SoC)* in high-risk patients with mild-to-moderate COVID-19 did not prevent progression to severe disease compared with SoC alone, according to results of the I-TECH** trial conducted in Malaysia.